178 related articles for article (PubMed ID: 26443922)
1. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.
Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X
Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922
[TBL] [Abstract][Full Text] [Related]
2. Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors.
Chen D; Cai J; Yin J; Jiang J; Jing C; Zhu Y; Cheng J; Di Y; Zhang Y; Cao M; Li S; Peng Z; Hao X
Future Med Chem; 2015; 7(5):561-70. PubMed ID: 25921398
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-HCV activity and SAR study of (+)-lycoricidine through targeting of host heat-stress cognate 70 (Hsc70).
Chen DZ; Jiang JD; Zhang KQ; He HP; Di YT; Zhang Y; Cai JY; Wang L; Li SL; Yi P; Peng ZG; Hao XJ
Bioorg Med Chem Lett; 2013 May; 23(9):2679-82. PubMed ID: 23511018
[TBL] [Abstract][Full Text] [Related]
4. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives.
Wang P; Li LF; Wang QY; Shang LQ; Shi PY; Yin Z
ChemMedChem; 2014 Jul; 9(7):1522-33. PubMed ID: 24574246
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiplasmodial activity of lycorine derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A
Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737
[TBL] [Abstract][Full Text] [Related]
6. A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus.
Guo Y; Wang Y; Cao L; Wang P; Qing J; Zheng Q; Shang L; Yin Z; Sun Y
Antimicrob Agents Chemother; 2016 Feb; 60(2):913-24. PubMed ID: 26596952
[TBL] [Abstract][Full Text] [Related]
7. Lycorine derivatives against Trichomonas vaginalis.
Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
[TBL] [Abstract][Full Text] [Related]
8. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives.
Evdokimov NM; Lamoral-Theys D; Mathieu V; Andolfi A; Frolova LV; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Kornienko A
Bioorg Med Chem; 2011 Dec; 19(23):7252-61. PubMed ID: 22019045
[TBL] [Abstract][Full Text] [Related]
9. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
10. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Structural Optimization of Lycorine-Derived Phenanthridine Derivatives as Wnt/β-Catenin Signaling Pathway Agonists.
Chen DZ; Jing CX; Cai JY; Wu JB; Wang S; Yin JL; Li XN; Li L; Hao XJ
J Nat Prod; 2016 Jan; 79(1):180-8. PubMed ID: 26714198
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of (-)-lycorine and (-)-2-epi-lycorine by asymmetric conjugate addition cascade.
Yamada K; Yamashita M; Sumiyoshi T; Nishimura K; Tomioka K
Org Lett; 2009 Apr; 11(7):1631-3. PubMed ID: 19243131
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
14. Catalytic asymmetric assembly of octahydroindolones: divergent synthesis of lycorine-type amaryllidaceae alkaloids (+)-α-lycorane and (+)-lycorine.
Sun Z; Zhou M; Li X; Meng X; Peng F; Zhang H; Shao Z
Chemistry; 2014 May; 20(20):6112-9. PubMed ID: 24700723
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity of new haemanthamine-type derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo ÁG; Estévez-Braun A
Bioorg Med Chem; 2012 Sep; 20(18):5464-72. PubMed ID: 22910226
[TBL] [Abstract][Full Text] [Related]
16. Lycorine: A prospective natural lead for anticancer drug discovery.
Roy M; Liang L; Xiao X; Feng P; Ye M; Liu J
Biomed Pharmacother; 2018 Nov; 107():615-624. PubMed ID: 30114645
[TBL] [Abstract][Full Text] [Related]
17. Activity of lycorine analogues against the fish bacterial pathogen Flavobacterium columnare.
Tan CX; Schrader KK; Mizuno CS; Rimando AM
J Agric Food Chem; 2011 Jun; 59(11):5977-85. PubMed ID: 21517109
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity and virtual screening by molecular docking of lycorine from Pancratium foetidum Pom (Moroccan endemic Amaryllidaceae).
Bendaif H; Melhaoui A; Ramdani M; Elmsellem H; Douez C; El Ouadi Y
Microb Pathog; 2018 Feb; 115():138-145. PubMed ID: 29253598
[TBL] [Abstract][Full Text] [Related]
20. N-substituted benzyl matrinic acid derivatives inhibit hepatitis C virus (HCV) replication through down-regulating host heat-stress cognate 70 (Hsc70) expression.
Du NN; Peng ZG; Bi CW; Tang S; Li YH; Li JR; Zhu YP; Zhang JP; Wang YX; Jiang JD; Song DQ
PLoS One; 2013; 8(3):e58675. PubMed ID: 23516533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
